HLS Therapeutics (HLTRF) Q3 2024 Earnings

Aug 8Confirmed
Aug 2022
Nov 2022
Q2 2024
Q3 2024
-0.28
-0.21
-0.14
-0.07

Details

Expected EPS
-0.152233
Actual EPS
-0.18
Surprise EPS
-0.03
Surprise Percent
-18.24%

Description

⁨HLS Therapeutics⁩ (⁦HLTRF⁩) has reported earnings of ⁦-0.18⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts